EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure‐Guided Identification and Evaluation of Epalrestat and Ranirestat‐Like Compounds Against Aldose Reductase: Therapeutic Management of Diabetic Neuropathy

Mohd Shahnawaz Khan, Dharmendra Kumar Yadav iD, Moyad Shahwan, Anas Shamsi iD

ChemistryOpen · 2025-12 · 14 (12)

DOI: 10.1002/open.202500110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistryOpen, online erschienen am 22.08.2025. Verfasst von Mohd Shahnawaz Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Science, King Saud University, Riyadh, 11451, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Aldehyde Reductase, Rhodanine, Thiazolidines, Diabetic Neuropathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Ongoing Research Funding Program, Ajman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aldose reductase (ALDR) is a critical protein involved in the pathogenesis of diabetic complications such as retinopathy, neuropathy, and nephropathy. Due to the activation of inflammatory and cytotoxic pathways under hyperglycemic conditions, ALDR has become an important target for therapeutic development. Currently, available drugs such as epalrestat and ranirestat are suboptimal due to factors such as toxicity and low solubility. In this study, a structure‐based approach was used to screen the PubChem database to identify novel ALDR inhibitors with a Tanimoto coefficient greater than 0.8 with the structural frameworks of epalrestat and ranirestat. A systematic virtual screening, including molecular docking, drug‐likeness assessment, and molecular dynamics (MD) simulations, revealed two promising candidates, PubChem CIDs: 45110135 and 58643777. These compounds showed higher binding and selectivity toward ALDR than epalrestat and ranirestat in docking studies. MD simulations supported the stability and preferred dynamics of their interactions with ALDR. These findings suggest that compounds CID:45110135 (N‐[3‐fluoro‐4‐(4‐fluoro‐1,3‐dioxoisoindol‐2‐yl)phenyl]pyridine‐2‐carboxamide) and CID:58643777 ([(5Z)‐4‐oxo‐2‐sulfanylidene‐5‐[[3‐[3‐(trifluoromethyl)phenyl]phenyl]methylidene]−1,3‐thiazolidin‐3‐yl]propanoic acid) might have the potential to be lead compounds for the development of new drugs for diabetic neuropathy after required validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aldehyde ReductaseRhodanineThiazolidinesDiabetic NeuropathiesEnzyme InhibitorsSpiro CompoundsMolecular Docking SimulationHumansMolecular Dynamics SimulationStructure-Activity RelationshipMolecular StructurePyrazines

Stichwörter der Autor:innen

aldose reductase inhibitorsbinding affinitydiabetic neuropathymolecular dynamics simulationsvirtual screening

Substanzen

Aldehyde ReductaseepalrestatRhodanineThiazolidinesEnzyme InhibitorsranirestatSpiro CompoundsPyrazines

Autor:innen und Institutionen

  • Department of Biochemistry, College of Science, King Saud University, Riyadh, 11451, Kingdom of Saudi Arabia.
  • Gachon Institute of Pharmaceutical Science and Department of Pharmacy, College of Pharmacy, Gachon University, Incheon, 21936, Republic of Korea.
  • Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, UAE.
  • Center of Excellence in Precision Medicine and Digital Health Department of Physiology, Faculty of Dentistry, Chulalongkorn University, Bangok, Thailand.
  • Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, 346, UAE.

ORCID-Profile: Dharmendra Kumar Yadav, Anas Shamsi

Förderung

  • King Saud University, Ongoing Research Funding Program
  • Ajman University

Zitieren

APA

Khan, M. S., Yadav, D. K., Shahwan, M., & Shamsi, A. (2025). Structure‐Guided Identification and Evaluation of Epalrestat and Ranirestat‐Like Compounds Against Aldose Reductase: Therapeutic Management of Diabetic Neuropathy. ChemistryOpen, 14(12). https://doi.org/10.1002/open.202500110

Vancouver

Khan MS, Yadav DK, Shahwan M, Shamsi A. Structure‐Guided Identification and Evaluation of Epalrestat and Ranirestat‐Like Compounds Against Aldose Reductase: Therapeutic Management of Diabetic Neuropathy. ChemistryOpen. 2025;14(12). doi:10.1002/open.202500110

BibTeX
@article{Khan2025,
  author = {Khan, Mohd Shahnawaz and Yadav, Dharmendra Kumar and Shahwan, Moyad and Shamsi, Anas},
  title = {Structure‐Guided Identification and Evaluation of Epalrestat and Ranirestat‐Like Compounds Against Aldose Reductase: Therapeutic Management of Diabetic Neuropathy},
  journal = {ChemistryOpen},
  year = {2025},
  volume = {14},
  number = {12},
  doi = {10.1002/open.202500110}
}
Kostenlos starten →